Use of pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP analogs as adjunctive treatments with anticancer agents

Details for Australian Patent Application No. 2009296456 (hide)

Owner The Administrators of the Tulane Educational Fund

Inventors Li, Min; Maderdrut, Jerome L.; Coy, David H.; Batuman, Vecihi

Agent Pizzeys

Pub. Number AU-A-2009296456

PCT Pub. Number WO2010/036936

Priority 61/194,166 25.09.08 US

Filing date 25 September 2009

Wipo publication date 1 April 2010

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/036936 Priority application(s): WO2010/036936

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296457-Topical formulations for treatment of neuropathy

2009296442-Profiling reactive oxygen, nitrogen and halogen species